President Trump's "Big, Beautiful" bill raises concerns over Medicare cuts. Lawmakers and experts weigh in on the implications for seniors

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

Trump is reviving his signature “most favored nation” policy from his first term, with a new push to get foreign countries to take on more of the costs of research and development.

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying the prices of certain Medicare-covered drugs to those paid by other developed countries.

President Donald Trump announced Sunday that he plans to resurrect a controversial policy from his first term that aims to reduce drug costs by basing payments for certain medicines on their prices in other countries.

which was seen as a budget cut by the insurance industry. The Trump administration increase will amount to $25 billion for insurers like Humana and UnitedHealthcare, which participate in the revitalized Medicare Advantage program. Advocates highlighted ...

The US spends $400 billion on prescription drugs every year — often triple what other countries spend and typically more than any other nation.

Senate Majority Leader John Thune (R-S.D.) has begun meeting privately with Senate Republicans who are threatening to derail President Trump’s “big, beautiful bill” over what they fear could be substantial cuts to Medicaid.